Evidence map›Paper›PMID 36115019›Full record

ArticleFEBS open bio2022

Characterisation of a common hotspot variant in acute intermittent porphyria sheds light on the mechanism of hydroxymethylbilane synthase function.

Marthe S Christie, Mikko Laitaoja, Aasne K Aarsand, Juha P Kallio, Helene J Bustad

Open access · goldAbstract read
In one paragraph

Article in FEBS open bio, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 3 countries.

Marthe S ChristieDepartment of Biomedicine, University of Bergen, Norway.ORCID 0000-0003-0213-518X
Mikko LaitaojaDepartment of Chemistry, University of Eastern Finland, Joensuu, Finland.ORCID 0000-0003-4516-8627
Aasne K AarsandNorwegian Porphyria Centre (NAPOS), Department for Medical Biochemistry and Pharmacology, Haukeland University Hospital, Bergen, Norway.ORCID 0000-0003-4167-8398
Juha P KallioDepartment of Biomedicine, University of Bergen, Norway.ORCID 0000-0003-3092-4012
Helene J BustadNorwegian Porphyria Centre (NAPOS), Department for Medical Biochemistry and Pharmacology, Haukeland University Hospital, Bergen, Norway.ORCID 0000-0002-4746-1563
Haukeland University Hospital · NOUniversity of Bergen · NOUniversity of Eastern Finland · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hydroxymethylbilane synthase (HMBS) is the third enzyme involved in haem biosynthesis, in which it catalyses the formation of tetrapyrrole 1-hydroxymethylbilane (HMB). In this process, HMBS binds four consecutive substrate molecules, creating the enzyme-intermediate complexes ES, ES

Indexed as

Hydroxymethylbilane SynthasePorphyria, Acute IntermittentHumansHydroxymethylbilane Synthaseacute intermittent porphyriacatalysishaemhydroxymethylbilane synthasemass spectrometrypolypyrroles

Identifiers

PMID36115019
PMCPMC9714363
OpenAlexW4296164032

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.